Cargando…
Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
Since the first identification of hypoxic cells in sections of carcinomas in the 1950s, hypoxia has been known as a central hallmark of cancer cells and their microenvironment. Indeed, hypoxia benefits cancer cells in their growth, survival, and metastasis. The historical discovery of hypoxia‐induci...
Autores principales: | Hayashi, Yoshihiro, Yokota, Asumi, Harada, Hironori, Huang, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501028/ https://www.ncbi.nlm.nih.gov/pubmed/30844107 http://dx.doi.org/10.1111/cas.13990 |
Ejemplares similares
-
Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
por: Kluckova, Katarina, et al.
Publicado: (2018) -
Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology
por: Stergiou, Ioanna E., et al.
Publicado: (2021) -
Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review
por: Liu, Lihui, et al.
Publicado: (2023) -
Hypoxia-mediated activation of hypoxia-inducible factor-1α in head and neck squamous cell carcinoma: A review
por: Hu, Lanxin, et al.
Publicado: (2023) -
Xanthine Oxidase Mediates Hypoxia-Inducible Factor-2α Degradation by Intermittent Hypoxia
por: Nanduri, Jayasri, et al.
Publicado: (2013)